z-logo
open-access-imgOpen Access
Temsirolimus: Is Improved Survival the Correct Expression of Drug Activity?
Author(s) -
Basso Michele,
Cassano Alessandra,
Schinzari Giovanni,
Barone Carlo
Publication year - 2010
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2010-0099
Subject(s) - medicine , temsirolimus , drug , oncology , pharmacology , anticancer drug , expression (computer science) , cancer research , bioinformatics , computational biology , discovery and development of mtor inhibitors , genetics , pi3k/akt/mtor pathway , apoptosis , biology , computer science , programming language
The article comments on the drug approval summary for temsirolimus published recently in The Oncologist in regard to the difference observed between the investigators' and independent reviewers' assessments.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here